SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ)

$9.56 -0.02 (-0.2088%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 56

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) News Sources

Sagimet Raises $115M At Premium To Fund Phase 3 Acne Drug Trial – SGMT Stock Surges Pre-Market

30-09-2026

stocktwits.com

Sagimet Biosciences Shares Rise 12% After Denifanstat Phase 3 Acne Trial Data

30-09-2026

advfn.com

Sagimet Biosciences Announces Closing of Underwritten Offering of Series A Common Stock and Pre-Funded Warrants

01-10-2026

yahoo.com

Sagimet Biosciences Highlights 52-Week Acne Data, Sets U.S. Phase III Trial Launch

04-10-2026

marketbeat.com

Sagimet To Present Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne and Mechanistic Data at the 2026 Fall Clinical Dermatology Conference

09-10-2026

yahoo.com

Sagimet Says Denifanstat Shows Continued Improvement in Acne Through 52 Weeks in China Trial

09-10-2026

yahoo.com

After Plunging 27.9% in 4 Weeks, Here's Why the Trend Might Reverse for Sagimet Biosciences Inc. (SGMT)

15-10-2026

yahoo.com

Sagimet Biosciences Announces First Patient Dosed in AURORA Phase 3 U.S. Clinical Trial of Denifanstat for Moderate to Severe Acne

22-10-2026

yahoo.com

Ascletis' Strategic Partner Sagimet Announces First Patient Dosed in Phase III U.S. Clinical Trial of Denifanstat (ASC40) for Moderate to Severe Acne

23-10-2026

yahoo.com

Wall Street Analysts Think Sagimet Biosciences Inc. (SGMT) Could Surge 168.24%: Read This Before Placing a Bet

23-10-2026

yahoo.com

SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) Sentiment Trend

0 25 50 75 100 88 81 25 83 79 25 2 86 83 8 30-09-2026 01-10-2026 04-10-2026 09-10-2026 15-10-2026 22-10-2026 23-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) FAQs

toggle

What is the current price of SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ)?

The current price of SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) is $9.56.


toggle

SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) absolute price change since previous trading day?

The absolute price change of SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) since the previous trading day is $-0.02.


toggle

SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) percentage price change since previous trading day?

The percentage price change of SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) since the previous trading day is -0.2088%.


toggle

What is the most recent average sentiment score for SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ)?

The most recent average sentiment score for SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) is 56 out of 100.


toggle

What is the most recent average sentiment for SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ)?

The most recent sentiment for SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) is .


SEC-8K** Filing Available For SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.